Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Fish and Richardson
Cantor Fitzgerald
Chinese Patent Office
Daiichi Sankyo
US Army
Accenture
McKesson

Generated: December 10, 2018

DrugPatentWatch Database Preview

Litigation Details for King Pharmaceuticals, Inc v. EON Labs, Inc. (E.D.N.Y 2004)

« Back to Dashboard

King Pharmaceuticals, Inc v. EON Labs, Inc. (E.D.N.Y 2004)

Docket ➤ Sign Up Date Filed 2004-12-17
Court District Court, E.D. New York Date Terminated 2011-03-11
Cause 35:145 Patent Infringement Assigned To Roslynn Renee Mauskopf
Jury Demand None Referred To Roanne L. Mann
Parties ELAN PHARMACEUTICALS, INC.; EON LABS, INC.; JONES PHARMA INC.; KING PHARMACEUTICALS, INC; MUTUAL PHARMACEUTICAL COMPANY, INC.; PETER L. MICHAELSON
Patents 6,407,128; 6,683,102
Attorneys Alfred Henry Hemingway; Darren Scott Mogil; Eileen Quinn Steiner; Eric C. Stops; Evangeline Shih; Francis Dominic Cerrito; James B. Monroe; James Edward Baker; Jennifer Marino Thibodaux; John J. Normile; Justin J. Hasford; Kakoli Caprihan; Kevin Joseph McKenna; Lawrence Ilag; Mara E Zazzali; Mara E. Zazzali-Hogan; Marilyn Neiman; Martin B. Pavane; Myron Cohen; Paul W. Browning; Peter Lee Michaelson; William A Alper; Yunling Ren
Firms Cohen, Pontani, Lieberman & Pavane; Darren Scott Mogil; Finnegan Henderson Farabow Garrett & Dunner LLP; Finnegan Henderson Farabow Garrett and Dunner; Finnegan, Henderson, Farabow, Garett & Dunner, LLP; Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.; Jones Day; Justin J. Hasford; Marilyn Neiman; Martin B Pavane; Michaelson & Associates
Link to Docket External link to docket
Small Molecule Drugs cited in King Pharmaceuticals, Inc v. EON Labs, Inc.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for King Pharmaceuticals, Inc v. EON Labs, Inc. (E.D.N.Y 2004)

Date Filed Document No. Description Snippet Link To Document
2004-12-17 1 653102132 US 6,683,102 32 .lau. 21', 2004 riot Patent No.: rest l'tate of Patent: [54] ME… (“Elan”) United 51tat11l Patent No. 11,40'1',121 (“the ’123 patent”) (attaehed hereto as Exhibit…1111 United States Patent and Trademark foiee issued to 1 ones United States Patent No. 6,183,102 (“the… expiration of 1111 ’121 patent, constitutes infringement of the ’123 patent. 19. l_lpon information …the expiration of the ’102 patent, constitutes infringement of the ’102 patent. 21 Pursuant to 35 U.S.C External link to document
2009-01-20 290 for infringement of U.S. Patents Nos. 6,407,128 ("the '128 patent") and 6,683,102 ("… b. The patents in suit i. The '128 patent The '128 patent contains twenty-two… The '102 patent The '102 patent is a continuation of the '128 patent and contains …. The patent on metaxalone was issued in 1962 and expired long ago. See U.S. Patent No. 3,062,827…test results, Elan filed a patent application with the United States Patent and Trademark Office, claiming External link to document
2010-09-28 356 two patents at issue in these actions are invalid. The two patents – U.S. Patent Nos. 6,407,128 ("… the patent as patent number 6,407,128. Eon Ex. 16. b. Prosecution of the '102 patent … application would eventually issue as patent number 6,407,128. 2 For ease of reference…"the '128 patent") and 6,683,102 ("the '102 patent") – both claim a new …The original patent on metaxalone issued in 1962 and expired long ago. See U.S. Patent No. 3,062,827 External link to document
2010-09-28 357 infringement of U.S. Patents Nos. 6,407,128 (“’128 patent”) and 6,683,102 (“’102 patent”), which disclose…King purchased the ’128 patent from Elan and then filed a continuation patent application, which resulted…resulted in the issuance of the ’102 patent. On January 20, 2009, in response to a summary judgment motion…issued a Memorandum and Opinion declaring those patents invalid as a matter of law. See Memorandum and …, 2010). The Court of Appeals agreed that both patents are invalid, but concluded that the district court External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Medtronic
Healthtrust
Fuji
Federal Trade Commission
Express Scripts
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.